The TGA works closely with overseas regulatory agencies.

• Therapeutic Goods (International Agreement-Notice of Prohibition) (Minamata Convention on Mercury) Instrument 2021
  9 August 2021: The Minamata Convention facilitates a global approach to address concerns relating to mercury, which is persistent, toxic and highly mobile in the environment once released, and recognised as a substance producing significant neurological and other effects in humans.
• Launch of international pilot programme on inspection of manufacturers of sterile medicines
  19 December 2019: TGA and its international partners are launching a pilot programme to increase their cooperation in the inspection of manufacturers of sterile medicines for human use
• Medical Device Single Audit Program (MDSAP)
  7 December 2016: The MDSAP aims to strengthen existing international cooperation in the field of medical device evaluation
• TGA participation in the IMDRF Table of Contents (ToC) pilot
  24 September 2015: The TGA will participate in the IMDRF pilot to trial the ToC submission format
• TGA joins EDQM's CEP assessment process
  17 June 2014: The TGA is set to strengthen its collaboration with the European Directorate for the Quality of Medicines and HealthCare (EDQM)
• Medical device amendments to the EU-Australia MRA on conformity assessment
  30 November 2012: Amendments come into effect on 1 January 2013
• Australia-United States Free Trade Agreement
  11 February 2005: The Australia-US Free Trade Agreement came into force on 1 January 2005